MassMutual Private Wealth & Trust’s Ultragenyx Pharmaceutical RARE Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Buy	60 +2	+3%	+$50	﹤0.01%	2006
2026 Q1	$1.22K	Hold	58	–	–	﹤0.01%	2094
2025 Q4	$1.33K	Hold	58	–	–	﹤0.01%	2090
2025 Q3	$1.75K	Sell	58 -125	-68%	-$3.75K	﹤0.01%	2023
2025 Q2	$6.65K	Buy	183 +105	+135%	+$3.79K	﹤0.01%	1522
2025 Q1	$2.82K	Sell	78 -93	-54%	-$3.87K	﹤0.01%	1815
2024 Q4	$7.19K	Buy	171 +153	+850%	+$7.59K	﹤0.01%	1391
2024 Q3	$1K	Hold	18	–	–	﹤0.01%	1851
2024 Q2	$740	Hold	18	–	–	﹤0.01%	1891
2024 Q1	$840	Hold	18	–	–	﹤0.01%	1748
2023 Q4	$861	Hold	18	–	–	﹤0.01%	1710
2023 Q3	$642	Buy	+18	New	+$713	﹤0.01%	1768
2022 Q3	–	Sell	-12	Closed	-$1K	–	1771
2022 Q2	$1K	Buy	+12	New	+$738	﹤0.01%	1386
2022 Q1	–	Sell	-12	Closed	-$1K	–	1612
2021 Q4	$1K	Buy	+12	New	+$976	﹤0.01%	1289
2017 Q4	–	Sell	-51	Closed	-$2.72K	–	962
2017 Q3	$2.72K	Buy	51 +1	+2%	+$59	﹤0.01%	904
2017 Q2	$3.11K	Sell	50 -3,440	-99%	-$207K	﹤0.01%	874
2017 Q1	$237K	Buy	+3,490	New	+$266K	0.02%	320

Other funds holding RARE

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

MassMutual Private Wealth & Trust's RARE Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Ultragenyx Pharmaceutical (RARE) stake by 3.4% in Q2 2026, buying an estimated $50 and bringing the position to 60 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #2006.

MassMutual Private Wealth & Trust first reported a position in RARE in Q1 2017 and has held it in 17 quarters since. The position peaked at $237K in Q1 2017. 53 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

MassMutual Private Wealth & Trust held 60 shares of Ultragenyx Pharmaceutical worth $2K as of Q2 2026.
MassMutual Private Wealth & Trust bought 2 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $50.
Ultragenyx Pharmaceutical made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2006 holding.
MassMutual Private Wealth & Trust first reported a position in Ultragenyx Pharmaceutical in Q1 2017 and has held it in 17 quarters since.
MassMutual Private Wealth & Trust's Ultragenyx Pharmaceutical position peaked at $237K in Q1 2017.
53 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.